PAS
ADVM

Point72 Asia (Singapore)’s Adverum Biotechnologies ADVM Stock Holding History

Point72 Asia (Singapore)’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,582
Closed -$31.4K – 876
2025
Q2 		$31.4K Buy
+14,582
New +$40.8K 0.01% 676
2024
Q2 		– Sell
-9,276
Closed -$131K – 1021
2024
Q1 		$131K Buy
+9,276
New +$141K 0.03% 561

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Point72 Asia (Singapore)'s ADVM Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Adverum Biotechnologies (ADVM) in Q3 2025, closing a stake of 14,582 shares — an estimated $31.4K sold.

Point72 Asia (Singapore) first reported a position in ADVM in Q1 2024 and held it in 2 quarters. The position peaked at $131K in Q1 2024. 50 funds tracked by Wall St. Rank hold ADVM as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Adverum Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 14,582 Adverum Biotechnologies shares in Q3 2025, an estimated $31.4K.
  • Point72 Asia (Singapore) first reported a position in Adverum Biotechnologies in Q1 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Adverum Biotechnologies position peaked at $131K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.